160 results on '"Wedderburn, L. R."'
Search Results
2. Genome-wide association study identifies HLA 8.1 ancestral haplotype alleles as major genetic risk factors for myositis phenotypes
3. Additional file 1 of Juvenile Dermatomyositis: what comes next? Long-term outcomes in childhood myositis from a patient perspective
4. Identification of Novel Associations and Localization of Signals in Idiopathic Inflammatory Myopathies Using Genome-Wide Imputation
5. Histological subtypes of juvenile dermatomyositis: O26
6. Histological heterogeneity in a large clinical cohort of juvenile idiopathic inflammatory myopathy: analysis by myositis autoantibody and pathological features
7. Tubuloreticular inclusions in juvenile dermatomyositis: A diagnostically useful marker?: P29
8. B cells correlate with histological and clinical features of muscle disease in patients with juvenile dermatomyositis: P28
9. Sub-phenotyping of juvenile dermatomyositis: O19
10. Genotyping of immune-related genetic variants identifies TYK2 as a novel associated locus for idiopathic inflammatory myopathies
11. Genome-wide data reveal novel genes for methotrexate response in a large cohort of juvenile idiopathic arthritis cases
12. Website for parents of children with juvenile idiopathic arthritis reduces parenting stress
13. You give me a name that I can’t say, but I have to explain what it is every day: the power of poetry to share stories from young people with a rare disease
14. Autoantibodies to a 140-kd protein in juvenile dermatomyositis are associated with calcinosis
15. The protein tyrosine phosphatase N22 gene is associated with juvenile and adult idiopathic inflammatory myopathy independent of the HLA 8.1 haplotype in British Caucasian patients
16. Age-dependent inhibition of ectopic calcification: a possible role for fetuin-A and osteopontin in patients with juvenile dermatomyositis with calcinosis
17. Clinical associations of autoantibodies to a p155/140 kDa doublet protein in juvenile dermatomyositis
18. HLA class II haplotype and autoantibody associations in children with juvenile dermatomyositis and juvenile dermatomyositis–scleroderma overlap
19. Autologous haematopoeitic stem cell rescue (AHSCR) for severe rheumatic disease in children: Guidance for BSPAR members—executive summary
20. The Juvenile Dermatomyositis National Registry and Repository (UK and Ireland)—clinical characteristics of children recruited within the first 5 yr
21. B Cells in Autoimmunity
22. Expansion and Enhanced Survival of Natural Killer Cells Expressing the Killer Immunoglobulin-Like Receptor KIR3DL2 in Spondylarthritis
23. Paediatric rheumatology: a bright future in the UK and Europe
24. Anti-BiP antibody levels in juvenile idiopathic arthritis (JIA)
25. Autologous stem cell transplantation for refractory juvenile idiopathic arthritis: analysis of clinical effects, mortality, and transplant related morbidity
26. Quantitative assessment of MRI T2 relaxation time of thigh muscles in juvenile dermatomyositis
27. Intravenous cyclophosphamide pulse therapy in juvenile dermatomyositis. A review of efficacy and safety
28. THE HYPORESPONSIVE PHENOTYPE OF SYNOVIAL T CELLS IN JUVENILE IDOPATHIC ARTHRITIS IS A PROPERTY OF CD4+CD25+ T CELLS: EVIDENCE FOR REGULATORY T CELLS IN JUVENILE ARTHRITIS
29. LONG-TERM MOLECULAR FOLLOW UP OF IMMUNE REPERTOIRE AFTER SEVERE IMMUNOSUPPRESSION AND AUTOLOGOUS STEM CELL RESCUE IN CHILDREN WITH JUVENILE IDIOPATHIC ARTHRITIS (JIA)
30. Synovial dendritic cells in juvenile idiopathic arthritis (JIA) express receptor activator of NF-κB (RANK)
31. Autologous haematopoietic stem cell transplantation in juvenile idiopathic arthritis
32. Autologous stem cell transplantation for paediatric-onset polyarteritis nodosa: changes in autoimmune phenotype in the context of reduced diversity of the T- and B-cell repertoires, and evidence for reversion from the CD45RO+ to RA+ phenotype
33. Expression of TRANCE and RANK in the inflamed joints of children with juvenile idiopathic arthritis (JIA)
34. The developing human immune system: T-cell receptor repertoire of children and young adults shows a wide discrepancy in the frequency of persistent oligoclonal T-cell expansions
35. A comparison of two techniques for the molecular tracking of specific T-cell responses; CD4+ human T-cell clones persist in a stable hierarchy but at a lower frequency than clones in the CD8+ population
36. Juvenile chronic arthritis
37. Effective induction therapy for anti-SRP associated myositis in childhood:A small case series and review of the literature
38. Fine-mapping the MHC locus in juvenile idiopathic arthritis (JIA) reveals genetic heterogeneity corresponding to distinct adult inflammatory arthritic diseases
39. You give me a name that I can't say, but I have to explain what it is every day: the power of poetry to share stories from young people with a rare disease.
40. Expression of myxovirus‐resistance protein A: a possible marker of muscle disease activity and autoantibody specificities in juvenile dermatomyositis
41. Fine-mapping the MHC locus in juvenile idiopathic arthritis (JIA) reveals genetic heterogeneity corresponding to distinct adult inflammatory arthritic diseases
42. HLA class II haplotype and autoantibody associations in children with juvenile dermatomyositis and juvenile dermatomyositis–scleroderma overlap
43. Expression of myxovirus‐resistance protein A: a possible marker of muscle disease activity and autoantibody specificities in juvenile dermatomyositis.
44. Morphometric analyses of normal pediatric brachial biceps and quadriceps muscle tissue
45. Adaptation of the methotrexate in rheumatoid arthritis knowledge questionnaire (MiRAK) for use with parents of children with juvenile idiopathic arthritis (JIA)
46. The Impact of Response to MTX on the Illness and Treatment Beliefs of Parents of Children with JIA
47. Delineation of the Innate and Adaptive T-Cell Immune Outcome in the Human Host in Response to Campylobacter jejuni Infection
48. Effective induction therapy for anti-SRP associated myositis in childhood: A small case series and review of the literature.
49. Concurrence of sarcoidosis and systemic lupus erythematosus in three patients
50. The lived experience of juvenile idiopathic arthritis in young people receiving etanercept.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.